viernes, 31 de julio de 2020

Fostemsavir | Dosificación, Efectos secundarios | infoSIDA

Fostemsavir | Dosificación, Efectos secundarios | infoSIDA

AIDSinfo logo Image

AIDSinfo Releases a Fact Sheet on Fostemsavir, a New HIV Medication
On July 2, the Food and Drug Administration (FDA) approved fostemsavir (brand name: Rukobia), a new antiretroviral medication that is used to treat HIV infection in treatment-experienced adults who meet certain requirements, as determined by a health care provider. Fostemsavir is always used in combination with other HIV medicines.

For more information about this drug, please see the new AIDSinfo fostemsavir fact sheet [en español].

Want to learn more about HIV medicines? Check out the AIDSinfo FDA-Approved HIV Medicines fact sheet and infographic.

Up-to-Date Information With AIDSinfo Apps
With AIDSinfo apps, you can use your Android or iOS device to access up-to-date information from the AIDSinfo Drug Database and the federally approved HIV/AIDS medical practice guidelines. To help you understand the terminology, AIDSinfo also has a Glossary app with more than 700 easy-to-understand, HIV-related definitions—in English and Spanish.

Visit AIDSinfo to download these free apps to your mobile device today.

Questions? Email AIDSinfo at

No hay comentarios:

Publicar un comentario